| Transcript | Q2 FY26 earnings call transcript |
| 2026-07-30 | Deck | Fulgent Investor Presentation |
| 2026-07-30 | Press release | Fulgent Reports Second Quarter 2026 Financial Results |
| 2026-07-30 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-30 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-09 | Press release | Fulgent to Announce Second Quarter 2026 Financial Results on Thursday |
| 2026-06-02 | 8-K | Form 8-K, Item 8.01 |
| 2026-06-01 | Press release | Fulgent Presents Updated FID-007 Data at ASCO 2026 |
| 2026-05-21 | Document | FID-007 ASCO Final Abstract |
| 2026-05-21 | Press release | Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting |
| 2026-05-21 | 8-K | Form 8-K, Item 8.01 |
| 2026-05-14 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-01 | Press release | Fulgent Reports First Quarter 2026 Financial Results |
| 2026-05-01 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-01 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-22 | Press release | Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting |
| 2026-04-16 | Press release | Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026 |
| 2026-03-31 | Proxy | Definitive proxy statement |
| Transcript | Q1 FY26 earnings call transcript |
| 2026-03-17 | Press release | Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx |
| 2026-03-17 | 8-K | Form 8-K, Item 1.01 |
| 2026-02-27 | Press release | Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-27 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-27 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-27 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-12 | Press release | Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 |
| 2025-12-22 | 8-K | Form 8-K, Item 1.01 |
| 2025-11-07 | Press release | Fulgent Reports Third Quarter 2025 Financial Results |
| 2025-11-07 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-07 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-20 | 8-K | Form 8-K, Item 8.01 |
| 2025-10-16 | Press release | Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025 |
| 2025-10-08 | Document | FID-007 ESMO 2025 Poster |
| 2025-08-01 | Press release | Fulgent Reports Second Quarter 2025 Financial Results |
| 2025-08-01 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-01 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-07-10 | Press release | Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025 |
| 2025-05-15 | 8-K | Form 8-K, Item 5.07 |
| 2025-05-02 | Press release | Fulgent Reports First Quarter 2025 Financial Results |
| 2025-05-02 | 8-K | Form 8-K, Item 2.02 results |